‹ ›
MYP_171784
Basic Information
Indium In-111 Pentetreotide
Anticancer ▸ Anti-proliferative
not Standard
8 amino acids
-
contains X representing unresolved or non-standard residue
Sequence
FCFWKTCX
Physicochemical Analysis
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available

Not available: incomplete physicochemical profile.

Molecular Weight
Not available
Isoelectric Point (pI)
Not available
Net Charge (pH 7.0)
Not available
GRAVY Index
Not available
Boman Index
Not available
Instability Index
Not available
The radar chart requires all six dimensions. Available values are listed above; missing values are not plotted as zero.
Residue Composition
Amino Acid Composition
Chemical Descriptors
Structural Visualization
3D PDB MODEL
Readable PDBLast file check: 2026-11-18T22:08:09.010892+00:00. File readability does not guarantee 3D display.
Match index: Listed
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0009075 REVIEWED: NO
Provenance & Taxonomy
Homo sapiens [Animal]; synthetic construct [Synthetic]
Somatostatin
9606;32630
Structure & Mods
disulfide-constrained cyclic peptide [Cyclic]
mixed L/D amino-acid peptide [Mixed]
DTPA
2-aminobutane-1,3-diol
2月7日
Non-standard residues/X at 8; DTPA
Bio-Activity Profile
Diagnostic imaging Somatostatin receptor imaging
Somatostatin receptor-positive neuroendocrine lesions
Clinical/Human: The maximum effective half-life of indium In 111 pentetreotide is 10 h.
RECORD: Rec_0405991 REVIEWED: YES
Provenance & Taxonomy
Homo sapiens [Animal]; synthetic construct [Synthetic]
Somatostatin
9606;32630
Structure & Mods
disulfide-constrained cyclic peptide [Cyclic]
mixed L/D amino-acid peptide [Mixed]
2月7日
Non-standard residues/X at 8
Bio-Activity Profile
Somatostatin receptor agonist Antisecretory Anti-proliferative
Human somatostatin receptors, especially SSTR2
Clinical/Human: 100 min (SC)